How does DNSP-11 work?
11-amino-acid peptide from the proGDNF domain (the prodomain of glial cell line-derived neurotrophic factor, GDNF). Pre-clinical neuroprotection via direct neurotrophic action on dopaminergic neurons. In plain terms, DNSP-11 is a compound studied to protect the brain cells lost in Parkinson's. An 11-amino-acid peptide from the proGDNF domain (the prodomain of glial cell line-derived neurotrophic factor, GDNF), also called Dopamine Neuron Stimulating Peptide-11. Pre-clinical neuroprotection for dopaminergic neurons in Parkinson's models. Mechanistic detail like this comes largely from preclinical and early research, the human picture is limited.
What people use it for
- Researchers studying Parkinson's disease pathways
- Neurodegeneration research contexts
- Educational reference, limited human data
References
- Dopamine neuron stimulating actions of a GDNF propeptide — Bradley LH, Fuqua J, Richardson A, et al. (Gerhardt GA group). PLoS One, 2010
- Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques — Stenslik MJ, Evans A, Pomerleau F, et al. (Gerhardt GA, Bradley LH groups). Journal of Neuroscience Methods, 2018
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on DNSP-11
Last updated 2026-06-06.